Literature DB >> 16385077

3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells.

Yixuan Gong1, Gary L Firestone, Leonard F Bjeldanes.   

Abstract

Epidemiological evidence suggests that high consumption of Brassica genus vegetables, such as broccoli, cabbage, and Brussels sprouts, is very effective in reducing the risks of several types of cancers. 3,3'-Diindolylmethane (DIM), one of the most abundant and biologically active dietary compounds derived from Brassica genus vegetables, displays remarkable antitumor activity against several experimental tumors. In the present study, we demonstrate for the first time that DIM is a novel catalytic topoisomerase IIalpha inhibitor. In supercoiled DNA relaxation assay and kinetoplast DNA decatenation assay, DIM strongly inhibited DNA topoisomerase IIalpha and also partially inhibited DNA topoisomerases I and IIbeta. DIM did not stabilize DNA cleavage complex and did not prevent etoposide-induced DNA cleavage complex formation. Further experiments showed that DIM inhibited topoisomerase IIalpha-catalyzed ATP hydrolysis, which is a necessary step for the enzyme turnover. In cultured human hepatoma HepG2 cells, DIM blocked DNA synthesis and mitosis in a concentration-dependent manner, which was consistent with the outcome of topoisomerase inhibition in these cell-cycle phases. Our results identified a new mode of action for this intriguing dietary component that might be exploited for therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385077     DOI: 10.1124/mol.105.018978

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Identification and preliminary characterization of novel small molecules that inhibit growth of human lung adenocarcinoma cells.

Authors:  Romel Somwar; David Shum; Hakim Djaballah; Harold Varmus
Journal:  J Biomol Screen       Date:  2009-12

2.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

Review 3.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

4.  A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide.

Authors:  Kyungsu Kang; Seung Hyun Oh; Ji Ho Yun; Eun Hye Jho; Ju-Hee Kang; Dulamjav Batsuren; Jigjidsuren Tunsag; Kwang Hwa Park; Minkyun Kim; Chu Won Nho
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

5.  Inhibition of topoisomerase II α activity and induction of apoptosis in mammalian cells by semi-synthetic andrographolide analogues.

Authors:  Jintapat Nateewattana; Rungnapha Saeeng; Sakkasem Kasemsook; Kanoknetr Suksen; Suman Dutta; Surawat Jariyawat; Arthit Chairoungdua; Apichart Suksamrarn; Pawinee Piyachaturawat
Journal:  Invest New Drugs       Date:  2012-08-17       Impact factor: 3.850

6.  Curcumin, thymoquinone, and 3, 3'-diindolylmethane combinations attenuate lung and liver cancers progression.

Authors:  Amna A Saddiq; Ali H El-Far; Shymaa Abdullah Mohamed Abdullah; Kavitha Godugu; Omar A Almaghrabi; Shaker A Mousa
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

Review 7.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

8.  A controlled safety study of diindolylmethane in the immature rat model.

Authors:  Alphi P Elackattu; Lining Feng; Zhi Wang
Journal:  Laryngoscope       Date:  2009-09       Impact factor: 3.325

9.  Development of derivatives of 3, 3'-diindolylmethane as potent Leishmania donovani bi-subunit topoisomerase IB poisons.

Authors:  Amit Roy; Sayan Chowdhury; Souvik Sengupta; Madhumita Mandal; Parasuraman Jaisankar; Ilda D'Annessa; Alessandro Desideri; Hemanta K Majumder
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 10.  Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3'-Diindolylmethane: A Therapeutic Marvel.

Authors:  V L Maruthanila; J Poornima; S Mirunalini
Journal:  Adv Pharmacol Sci       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.